ST. LOUIS/ Jan. 16, 2018 (STL.NEWS) — Canopy Biosciences TM, LLC, a leading provider of gene editing and personalized medicine technologies, announced today that it has launched two novel services for immuno-oncology and Neurodegenerative Disease. Both

The post Canopy Biosciences Offers Novel Tools to Help Fight Neurodegenerative Disease and Cancer appeared first on STL News - ST Louis Latest News Updates -st local news, stl poltical news.